Avita Medical(RCEL)
$17.30-0.35 (-1.98%)
RCEL
Avita Medical financials statements
$17.30
At close:-0.35 (-1.98%)
Want to see RCEL full AI Analyst Report?
Avita Medical (RCEL) Ratios
438 Followers
Avita Medical Ratios
RCEL's free cash flow for Q3 2026 was AU$-821.00K. For the 2026 fiscal year, RCEL's free cash flow was decreased by AU$-111.00K and operating cash flow was AU$-710.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.57 | 2.83 | 7.88 | 8.18 | 10.07 |
| Quick Ratio | 0.46 | 2.47 | 7.46 | 7.98 | 9.84 |
| Cash Ratio | 0.16 | 0.70 | 1.68 | 1.70 | 6.07 |
| Solvency Ratio | -0.63 | -0.81 | -0.56 | -1.93 | -2.15 |
| Operating Cash Flow Ratio | -0.50 | -2.43 | -2.88 | -1.79 | -1.97 |
| Short-Term Operating Cash Flow Coverage | -0.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ -37.55M | AU$ -18.21M | AU$ 41.42M | AU$ 73.93M | AU$ 80.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.82 | 0.58 | 0.38 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | -2.77 | 10.22 | 0.86 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 1.57 | 0.91 | 0.46 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.90 | 0.45 | 0.00 | 0.00 |
| Financial Leverage Ratio | -3.39 | 17.72 | 2.28 | 1.16 | 1.11 |
| Debt Service Coverage Ratio | -0.86 | -10.33 | -29.40 | 0.00 | -842.93 |
| Interest Coverage Ratio | -8.50 | -10.56 | -37.32 | 0.00 | -866.14 |
| Debt to Market Cap | 0.45 | 0.13 | 0.11 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.83 | 1.98 | 1.72 | 0.04 | 0.07 |
| Net Debt to EBITDA | -0.87 | -0.58 | -0.60 | 0.66 | 2.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 82.13% | 85.85% | 84.48% | 82.45% | 81.52% |
| EBIT Margin | -60.85% | -87.83% | -68.15% | -77.32% | -75.93% |
| EBITDA Margin | -57.57% | -86.07% | -66.89% | -75.67% | -73.89% |
| Operating Profit Margin | -59.40% | -88.08% | -85.07% | -79.91% | -76.06% |
| Pretax Profit Margin | -67.83% | -96.17% | -70.43% | -77.36% | -76.00% |
| Net Profit Margin | -67.85% | -96.26% | -70.56% | -77.47% | -76.13% |
| Continuous Operations Profit Margin | -67.85% | -96.26% | -70.56% | -77.47% | -76.13% |
| Net Income Per EBT | 100.02% | 100.09% | 100.19% | 100.14% | 100.17% |
| EBT Per EBIT | 114.21% | 109.18% | 82.79% | 96.82% | 99.93% |
| Return on Assets (ROA) | -86.16% | -77.59% | -31.69% | -27.14% | -21.67% |
| Return on Equity (ROE) | 291.81% | -1374.64% | -72.12% | -31.47% | -24.03% |
| Return on Capital Employed (ROCE) | 676.75% | -95.03% | -43.33% | -31.41% | -23.50% |
| Return on Invested Capital (ROIC) | -113.04% | -93.61% | -42.94% | -31.19% | -23.35% |
| Return on Tangible Assets | -95.74% | -83.42% | -31.83% | -27.27% | -21.75% |
| Earnings Yield | -50.55% | -18.67% | -10.18% | -16.16% | -8.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.86 | 5.37 | 6.33 | 6.94 | 9.64 |
| Payables Turnover | 1.43 | 1.44 | 2.05 | 2.01 | 2.25 |
| Inventory Turnover | 1.85 | 1.25 | 1.39 | 2.84 | 2.86 |
| Fixed Asset Turnover | 6.21 | 4.73 | 11.62 | 16.78 | 11.77 |
| Asset Turnover | 1.27 | 0.81 | 0.45 | 0.35 | 0.28 |
| Working Capital Turnover Ratio | 14.83 | 1.01 | 0.60 | 0.43 | 0.34 |
| Cash Conversion Cycle | -11.58 | 107.09 | 142.25 | -0.39 | 3.42 |
| Days of Sales Outstanding | 46.42 | 67.96 | 57.66 | 52.60 | 37.86 |
| Days of Inventory Outstanding | 197.59 | 291.75 | 262.54 | 128.39 | 127.49 |
| Days of Payables Outstanding | 255.59 | 252.62 | 177.95 | 181.38 | 161.93 |
| Operating Cycle | 244.01 | 359.71 | 320.20 | 180.99 | 165.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.12 | -1.89 | -1.50 | -0.76 | -0.74 |
| Free Cash Flow Per Share | -1.18 | -2.25 | -1.56 | -0.78 | -0.76 |
| Dividend Paid and CapEx Coverage Ratio | -17.94 | -5.24 | -26.27 | -36.36 | -37.04 |
| Capital Expenditure Coverage Ratio | -17.94 | -5.24 | -26.27 | -36.36 | -37.04 |
| Operating Cash Flow Coverage Ratio | -0.68 | -1.06 | -0.90 | -20.80 | -11.01 |
| Operating Cash Flow to Sales Ratio | -0.44 | -0.76 | -0.76 | -0.55 | -0.55 |
| Free Cash Flow Yield | -34.26% | -17.59% | -11.35% | -11.89% | -6.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.98 | -5.36 | -9.82 | -6.19 | -11.61 |
| Price-to-Sales (P/S) Ratio | 1.34 | 5.16 | 6.93 | 4.79 | 8.84 |
| Price-to-Book (P/B) Ratio | -5.77 | 73.64 | 7.08 | 1.95 | 2.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.92 | -5.69 | -8.81 | -8.41 | -15.75 |
| Price-to-Operating Cash Flow Ratio | -3.08 | -6.77 | -9.14 | -8.64 | -16.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | -0.08 | 0.91 | -0.12 | 0.23 |
| Enterprise Value Multiple | -3.20 | -6.57 | -10.97 | -5.67 | -9.75 |
| Enterprise Value | 131.92M | 363.24M | 367.84M | 147.76M | 237.92M |
| EV to EBITDA | -3.20 | -6.57 | -10.97 | -5.67 | -9.75 |
| EV to Sales | 1.84 | 5.65 | 7.34 | 4.29 | 7.20 |
| EV to Free Cash Flow | -4.01 | -6.23 | -9.32 | -7.53 | -12.84 |
| EV to Operating Cash Flow | -4.23 | -7.42 | -9.68 | -7.74 | -13.19 |
| Tangible Book Value Per Share | -0.80 | -0.04 | 1.92 | 3.37 | 4.28 |
| Shareholders’ Equity Per Share | -0.60 | 0.17 | 1.94 | 3.39 | 4.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 2.57 | 2.48 | 1.98 | 1.38 | 1.36 |
| Net Income Per Share | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.11 | 1.10 | 1.03 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.29 | 0.32 | 0.42 | 0.40 | 0.47 |
| SG&A to Revenue | 1.12 | 1.42 | 0.57 | 0.68 | 0.63 |
| Stock-Based Compensation to Revenue | 0.13 | 0.21 | 0.17 | 0.20 | 0.19 |
| Income Quality | 0.64 | 0.79 | 1.07 | 0.72 | 0.72 |
Currency in AUD
